Viewing nowCombinationEmpagliflozin Duo 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Palmgen Science Co., Ltd.

MFDS item code 202302608 · Approved 2023.09.01 · Insurance code 670105510
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication helps adult patients with type 2 diabetes control their blood sugar levels when used in conjunction with diet and exercise. It is particularly suitable for those whose blood sugar is hard to control and can be used effectively in cases of cardiovascular disease. For more detailed information on the occurrence of cardiovascular events, please refer to professional information. This medication is used to improve blood sugar management in patients with type 2 diabetes.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This drug can cause a rare but fatal side effect called severe lactic acidosis, so it should not be used in patients with poor renal function or in acute conditions such as severe infections, dehydration, or heart disease. Additionally, caution should be exercised when used with other diabetes medications such as insulin or sulfonylureas due to the risk of hypoglycemia. Renal function should be regularly checked to ensure it is normal, and the medication should be discontinued if renal function declines. The medication should be temporarily discontinued before and after tests involving iodine contrast media due to the risk of kidney damage and lactic acidosis. Women who are pregnant or breastfeeding should not use this medication and women of childbearing potential should avoid it as well. Elderly patients or those at risk of fluid loss should watch for dehydration or hypotension, and may need to temporarily stop taking the medication as necessary. This medication may increase urine output and thereby raise the risk of urinary tract infections or genital infections; therefore, if symptoms of infection occur, consult a doctor immediately. Gastrointestinal disturbances (such as diarrhea, nausea, vomiting) associated with the metformin component can frequently occur, and vitamin B12 levels may decrease, so regular checking is necessary. Alcohol consumption is best avoided during the course of treatment, and if symptoms such as sudden weight loss, abdominal pain, difficulty breathing, weakness appear, seek hospital care immediately. Furthermore, there may be interactions with other medications used concurrently, so always inform healthcare professionals of any medications being taken. This medication is not recommended for children, and dose adjustments are needed for the elderly based on kidney function. In the case of overdose, immediate medical attention is required as hemodialysis may be necessary. Finally, this medication should be stored out of reach of children and kept in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. The storage temperature should be maintained between 1 and 30 degrees Celsius to preserve the drug's effectiveness for a longer time.
Light brownish purplish, oval, bilaterally convex film-coated tablet
10 tablets/box [10 tablets/PTP x 1], 60 tablets/box [10 tablets/PTP x 6], 60 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Palmgen Science Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.